Moo Jun Baek

1.7k total citations
87 papers, 1.3k citations indexed

About

Moo Jun Baek is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Moo Jun Baek has authored 87 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Oncology, 38 papers in Molecular Biology and 15 papers in Cancer Research. Recurrent topics in Moo Jun Baek's work include Colorectal Cancer Surgical Treatments (9 papers), Colorectal Cancer Treatments and Studies (9 papers) and Genetic factors in colorectal cancer (7 papers). Moo Jun Baek is often cited by papers focused on Colorectal Cancer Surgical Treatments (9 papers), Colorectal Cancer Treatments and Studies (9 papers) and Genetic factors in colorectal cancer (7 papers). Moo Jun Baek collaborates with scholars based in South Korea, United States and Puerto Rico. Moo Jun Baek's co-authors include Dongjun Jeong, Sang Hun Lee, Yong‐Seok Han, Tae Sung Ahn, Moon Soo Lee, Hae Il Jung, Sang Ho Bae, Hyung Chul Kım, Hyungjoo Kim and Hyog Young Kwon and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Moo Jun Baek

81 papers receiving 1.3k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Moo Jun Baek 532 492 245 196 174 87 1.3k
Dongjun Jeong 798 1.5× 528 1.1× 294 1.2× 268 1.4× 202 1.2× 55 1.6k
Shujie Zhao 755 1.4× 570 1.2× 317 1.3× 172 0.9× 232 1.3× 17 1.5k
Chenyue Zhang 680 1.3× 578 1.2× 465 1.9× 303 1.5× 198 1.1× 74 1.4k
Xiaofeng Chen 558 1.0× 409 0.8× 260 1.1× 226 1.2× 184 1.1× 63 1.2k
Yongfu Xiong 516 1.0× 254 0.5× 312 1.3× 211 1.1× 102 0.6× 56 1.0k
Cinzia Bagalá 629 1.2× 484 1.0× 198 0.8× 177 0.9× 251 1.4× 36 1.3k
Guanglong Dong 874 1.6× 378 0.8× 601 2.5× 232 1.2× 197 1.1× 76 1.6k
Matthias Ilmer 837 1.6× 667 1.4× 341 1.4× 194 1.0× 319 1.8× 68 1.7k
Jianting Long 784 1.5× 290 0.6× 512 2.1× 125 0.6× 81 0.5× 51 1.2k
E. Kay 496 0.9× 365 0.7× 267 1.1× 158 0.8× 149 0.9× 47 1.2k

Countries citing papers authored by Moo Jun Baek

Since Specialization
Citations

This map shows the geographic impact of Moo Jun Baek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Moo Jun Baek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Moo Jun Baek more than expected).

Fields of papers citing papers by Moo Jun Baek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Moo Jun Baek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Moo Jun Baek. The network helps show where Moo Jun Baek may publish in the future.

Co-authorship network of co-authors of Moo Jun Baek

This figure shows the co-authorship network connecting the top 25 collaborators of Moo Jun Baek. A scholar is included among the top collaborators of Moo Jun Baek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Moo Jun Baek. Moo Jun Baek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kim, Han Jo, Min‐Ho Lee, Chang‐Jin Kim, et al.. (2025). CYP4X1 Expression Is Associated with Metastasis and Poor Prognosis in Patients with Colorectal Cancer. International Journal of Molecular Sciences. 26(5). 1867–1867.
2.
Singh, Tejinder, Tae Wan Kim, Keon‐Hyoung Song, et al.. (2023). Tumor–homing peptide iRGD-conjugate enhances tumor accumulation of camptothecin for colon cancer therapy. European Journal of Medicinal Chemistry. 265. 116050–116050. 9 indexed citations
3.
Jung, Hae Il, Hyein Ahn, Mee‐Hye Oh, et al.. (2023). Prognostic significance of programmed cell death-ligand 1 expression on immune cells and epithelial-mesenchymal transition expression in patients with hepatocellular carcinoma. Annals of Surgical Treatment and Research. 105(5). 297–297. 1 indexed citations
4.
Lee, Minho, et al.. (2023). High Expression of Tetraspanin 5 as a Prognostic Marker of Colorectal Cancer. International Journal of Molecular Sciences. 24(7). 6476–6476. 3 indexed citations
5.
Ahn, Tae Sung, et al.. (2023). Clinical influence of neoadjuvant chemoradiotherapy on immunonutritional status in locally advanced rectal cancer. SHILAP Revista de lepidopterología. 19(1). 3–10. 1 indexed citations
6.
Kim, Doyeon, Tae Sung Ahn, Moon Soo Lee, et al.. (2022). Expression of Spermine Oxidase Is Associated with Colorectal Carcinogenesis and Prognosis of Patients. Biomedicines. 10(3). 626–626. 10 indexed citations
7.
Kim, Hyun Jung, et al.. (2021). Clinical relevance and prognostic role of preoperative cell-free single-stranded DNA concentrations in colorectal cancer patients. SHILAP Revista de lepidopterología. 17(2). 59–67. 2 indexed citations
8.
Son, Myoung Won, Geum Jong Song, Si‐Hyong Jang, et al.. (2017). Clinicopathological Significance of Large Tumor Suppressor (LATS) Expression in Gastric Cancer. Journal of the Korean Gastric Cancer Association. 17(4). 363–363. 8 indexed citations
9.
Lee, Chang‐Seuk, Hyungjoo Kim, Su Yu, et al.. (2017). Doxorubicin-loaded oligonucleotide conjugated gold nanoparticles: A promising in vivo drug delivery system for colorectal cancer therapy. European Journal of Medicinal Chemistry. 142. 416–423. 87 indexed citations
10.
Ban, Myung Jin, Sang Byung Bae, Han Jo Kim, et al.. (2017). Solute carrier organic anion transporter family member 4A1 (SLCO4A1) as a prognosis marker of colorectal cancer. Journal of Cancer Research and Clinical Oncology. 143(8). 1437–1447. 22 indexed citations
11.
Kim, Hyungjoo, Tae Sung Ahn, Chang‐Jin Kim, et al.. (2017). Oncogenic function of angiopoietin-2 in vitro and its modulation of tumor progression in colorectal carcinoma. Oncology Letters. 14(1). 553–560. 6 indexed citations
12.
Han, Yong‐Seok, Jun Hee Lee, Jin Sup Jung, et al.. (2015). Fucoidan protects mesenchymal stem cells against oxidative stress and enhances vascular regeneration in a murine hindlimb ischemia model. International Journal of Cardiology. 198. 187–195. 48 indexed citations
13.
Jeong, Dongjun, Hyungjoo Kim, Chang‐Jin Kim, et al.. (2015). RhoA is associated with invasion and poor prognosis in colorectal cancer. International Journal of Oncology. 48(2). 714–722. 35 indexed citations
14.
Kim, Jung Han, Moo Jun Baek, Byung-Kwon Ahn, et al.. (2015). Clinical Practice in the Use of Adjuvant Chemotherapy for Patients with Colon Cancer in South Korea: a Multi-Center, Prospective, Observational Study. Journal of Cancer. 7(2). 136–143. 5 indexed citations
15.
Baek, Moo Jun, et al.. (2008). Expression of RhoC Is Associated with Metastasis of Colorectal Carcinomas. 14(1). 319–328. 1 indexed citations
16.
Baek, Moo Jun, Chang‐Jin Kim, Jae-Jun Kim, et al.. (2006). Expression of Survivin and Its Correlation with Prognosis in Colorectal Cancer. 22(2). 125–131. 1 indexed citations
17.
Kim, Sung Yong, et al.. (2006). Expression of survivin and clinical correlation in patients with breast cancer. Biomedicine & Pharmacotherapy. 60(6). 289–292. 45 indexed citations
18.
Bae, Sang Ho, Taeyun Kim, Sung Yong Kim, et al.. (2002). Analysis of Factors Influencing Morbidity and Mortality after Pancreaticoduodenectomy.. Journal of the Korean Surgical Society. 62(6). 496–502. 15 indexed citations
19.
Baek, Moo Jun, et al.. (2000). Focal Nodular Hyperplasia of the Liver. Journal of the Korean Surgical Society. 58(1). 132–137. 4 indexed citations
20.
Baek, Moo Jun, et al.. (1998). Annular Pancreas in Adult. Journal of the Korean Surgical Society. 54(2). 294–298. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026